Caribou Biosciences, Inc.

CRBUNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$11.2M

▲ 11.7% YoY

Net Income

-$148.1M

▲ 0.7% YoY

EPS

$-1.59

▲ 3.6% YoY

Cash

$12.4M

▼ 24.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.